Amphista Therapeutics



Amphista Therapeutics announces £38m investment round

Amphista Therapeutics, a University of Dundee spin-out company, has announced a £38 million investment round that will further its work to develop new drugs for a range of diseases.

Published 17 March 2021

Amphista Therapeutics closes £6m funding round

Amphista Therapeutics, a University of Dundee spin-out, has announced a multi-million-pound deal to develop first-in-class cancer therapeutics that harness the body’s natural processes to selectively and efficiently degrade and remove disease-causing proteins.

Published 7 April 2020